Meraki Methylene Blue Review (2026): Purity, Testing & How It Compares

Last updated: September 2, 2026 · By NooBlue Research Team

Meraki Medicinal has become one of the most searched methylene blue names in the United States, and most of that interest comes down to one question: is it actually worth the money, and is it as pure as the marketing says? This review breaks down what Meraki Blu offers, where the brand is genuinely strong, where the claims get shaky, and how it stacks up against a pharmaceutical-grade alternative on the metrics that decide whether methylene blue does anything at all — purity, dose accuracy, and testing transparency.

What Meraki Methylene Blue Is

Meraki Blu is a USP-grade methylene blue product sold by Meraki Medicinal, a US company based in Las Vegas. The brand was started by a former MMA athlete who turned to methylene blue after a head injury, and the founder story is built around a reaction to contamination problems in the wider methylene blue market. The flagship SKU is a 150 mg solution sold direct-to-consumer, with a liquid dropper format positioned for cognitive and cellular energy support.

The positioning is aggressive on quality: USP pharmaceutical grade, made in a US cGMP facility, no fillers, no flavoring, and the claim that every batch goes through four independent third-party tests covering heavy metals, microbial contamination, potency, and purity, with the Certificates of Analysis published publicly. On paper, that is the kind of testing depth most of the market does not offer. The marketing figure is 99.9% purity, with some pages citing 99.99%.

Where it gets interesting is that the claims and the independent reviews do not fully agree, and that gap is the entire reason to read a COA before buying anything in this category — Meraki included.

Purity and Testing: Reading Past the Marketing

Four-test-per-batch coverage is a real differentiator if every batch genuinely clears every test. The problem is that “we test for X” and “we pass X” are different statements, and the public conversation around Meraki contains both glowing third-party rankings and at least one independent assessment flagging a high microbial count on a tested unit. Two reviewers looking at the same brand reaching opposite conclusions is not unusual in this market — it is exactly why the COA, not the homepage, is the document that matters.

When you pull a methylene blue COA, four numbers decide everything. Assay (actual methylene blue content as a percentage of label) should sit at or very near 99%+ for a USP claim. Heavy metals — arsenic, lead, cadmium, mercury — should be below USP limits, ideally with the actual measured values printed, not just “pass.” Total aerobic microbial count and yeast/mold count should be well within USP <1111> limits; a four-figure CFU/mL reading is the kind of thing that should make you pause regardless of how the brand frames it. And the COA should be batch-matched to the bottle you received, not a generic sample document. If you want the full walkthrough, our guide to reading a methylene blue Certificate of Analysis covers each line in detail.

The practical takeaway with Meraki: the testing program is marketed well, but the only way to verify it for the specific bottle in your hand is the batch-specific COA. If a brand publishes COAs publicly, match the batch number. If it can’t produce one for your batch, the depth of the testing program is irrelevant to you.

Does the Dose Actually Do Anything?

This is where format and dose accuracy matter more than brand identity. The research on methylene blue and cognition is built almost entirely on low, precisely controlled doses. According to PubMed, a double-blind randomized controlled trial by Telch and colleagues in the American Journal of Psychiatry found that a single low dose of methylene blue administered after a learning task improved memory retention and the durability of fear extinction in adults, while the same compound produced no benefit (and in some cases the opposite) when conditions weren’t right — a clean demonstration that the effect is dose- and context-dependent, not a “more is better” compound (Telch et al., 2014; DOI).

The mechanism behind that is mitochondrial. Based on articles retrieved from PubMed, a review by Gonzalez-Lima, Barksdale and Rojas in Biochemical Pharmacology describes how low-dose USP methylene blue increases brain mitochondrial respiration by donating electrons into the respiratory chain, and that this bioenergetic effect — not a stimulant action — is what links it to memory enhancement and neuroprotection, with a hormetic dose-response curve where low doses help and high doses lose the benefit (Gonzalez-Lima et al., 2014; DOI).

Two things follow from this for anyone evaluating Meraki or any other brand. First, a 150 mg bottle is a container size, not a dose — the dose that matters is the few milligrams you actually take, and you can only hit that consistently if the concentration on the label is accurate and the dropper is predictable. Second, purity is not cosmetic. Research-grade methylene blue can carry contaminants that pharmaceutical USP grade screens out, and the studies showing benefit used USP-grade material. A brand can have an inspiring origin story and still ship a bottle where the assay drifts batch to batch. The science rewards precision, so the buying decision should too. For the difference between grades, see our breakdown of lab grade vs pharmaceutical grade methylene blue.

Meraki vs a Pharmaceutical-Grade Alternative

Stripped of branding, here is how the comparison actually shapes up across the factors that change outcomes:

Grade. Both Meraki Blu and NooBlue position as pharmaceutical/USP grade. This is the price of entry, not a differentiator — treat any brand that can’t clearly state and document its grade as disqualified.

Testing transparency. Meraki markets a four-test program with public COAs. NooBlue publishes batch-matched Certificates of Analysis as well. The right move with either brand is identical: don’t trust the count of tests advertised, verify the COA for your batch number. The presence of conflicting independent assessments of Meraki is precisely the argument for batch-level verification rather than brand loyalty.

Dose control. The research case for methylene blue lives at low, accurate doses. A predictable concentration and a consistent delivery format are worth more than a large bottle. Capsules remove the guesswork that a dropper introduces; a standardized solution with a clear concentration is the liquid equivalent. NooBlue offers both a fixed-dose capsule and a defined-concentration 1% solution for exactly this reason.

Value. Cost per accurate dose — not cost per bottle — is the number that matters. A cheaper bottle that you can’t dose consistently is more expensive in practice than a slightly pricier product you can. Run the per-dose math, not the sticker comparison. Our tested comparison of methylene blue supplements works through this for the major US brands.

Customer experience. Some buyers have reported billing and cancellation friction with Meraki’s direct-to-consumer flow. That doesn’t speak to product chemistry, but subscription clarity and refund handling are legitimate parts of a purchase decision, so check the terms before you check out.

Meraki Blu Pricing: What You Actually Pay Per Dose

Meraki Medicinal sells its flagship — branded Meraki Blu, though many people search for it as “Meraki blue” — as a single 30 ml dropper bottle holding 150 mg of methylene blue, priced around $35. That is 5 mg per milliliter — a 0.5% solution, half the strength of a standard 1% product — so a full 1 ml dropper is roughly 5 mg and the bottle yields about 30 low-dose servings, which works out to roughly $1.17 per 5 mg dose. That is a premium number in this category: it is nearly four times the cost per dose of a larger 50 ml 1% solution, and more than a fixed-dose USP capsule, largely because the 30 ml bottle, at half the concentration, holds under a third of the total milligrams of a 50 ml 1% bottle.

None of that makes Meraki a bad product — it makes it a small, premium-priced one. The value question is the same as the purity question: run the math on cost per accurate dose, not cost per bottle. A small bottle you have to ration carefully can cost more in practice than a larger, defined-concentration solution or a pre-measured capsule. For a side-by-side on exactly this, see our NooBlue vs Meraki methylene blue comparison, which puts the two bottles, concentrations, and per-dose costs next to each other.

Meraki Blu Dosing: How Many Drops Per Day, and What That Actually Costs

The most common practical question about any methylene blue liquid is how many drops to use, and the answer depends entirely on concentration. Meraki Blu holds 150 mg in 30 ml, which is 5 mg per milliliter (a 0.5% solution), so the included 1 ml dropper filled once delivers roughly 5 mg — about 20 drops from a standard dropper — and a 10 mg serving is two full droppers. A 1% solution such as NooBlue’s is twice as concentrated at 10 mg per milliliter, so the same 5 mg is half a milliliter, around ten drops. Those are arithmetic estimates from the stated concentrations, not a dosing instruction — droppers vary, viscosity varies, and the only figure that binds is the serving size printed on the label of the bottle you own.

That arithmetic is also the whole argument about liquids. Ten drops counted by hand into a glass of water is a genuinely different act from swallowing a pre-measured unit, and the gap between the two shows up as dose variance across a month rather than as an obvious mistake on any single day. If you enjoy the control a dropper gives you, a liquid is the right format. If counting drops every morning is the step you are most likely to rush or skip, a fixed unit removes the variable entirely. We work through the trade-off in detail in our comparison of methylene blue gummies vs liquid, and our guide to how many mg of methylene blue per day covers where the low-dose range sits.

On cost, the per-dose numbers matter more than the shelf price, and they are easy to check. Meraki Blu’s 30 ml bottle holds 150 mg in total; a 50 ml bottle at 1% holds 500 mg, which is why the larger format lands so far below it on cost per milligram. Normalized to the same 5 mg of methylene blue, NooBlue’s 1% solution works out at about $0.30, the 5 mg capsule at about $0.63, and the 10 mg gummy at about $0.42 — the gummy sells for $49.99 for a 60-day supply, or roughly $0.83 for its full 10 mg serving. The 1% solution is the lowest cost per milligram of the three; the gummy is the one people actually remember to take.

What About Meraki Methylene Blue Gummies?

“Meraki methylene blue gummies” is a recurring related search, and it is worth being precise about what is behind it: most searchers are not looking for a specific Meraki SKU so much as asking whether the gummy format is a sensible way to take methylene blue at all. That question deserves a straight answer, because the format has a real and well-earned reputation problem.

The complaints attached to candy-grade and marketplace methylene blue gummies are legitimate ones. Conventional gummies carry methylene blue in its ordinary oxidized state, which is intensely blue and will tint the mouth and tongue on the way down. Many are built on a sugar base. And a large share of the listings on open marketplaces publish no batch-matched Certificate of Analysis at all, which makes the dose on the label an assertion rather than a measurement. Those criticisms apply squarely to that class of product.

They are not, however, a property of gummies as a category — they are a property of how most gummies have been made. NooBlue’s Methylene Blue Gummies pair 10 mg of USP methylene blue with 25 mg of vitamin C in the same gummy, and the vitamin C reduces the methylene blue to leucomethylene blue — the colorless, electron-loaded reduced form — before it ever reaches your mouth. That is why the gummy is purple from Wild Blueberry extract rather than blue from the dye, and why it arrives without the blue-mouth mess a conventional gummy produces. It is zero sugar, precisely dosed at 10 mg, and ships with a published CTLA Certificate of Analysis. No oral methylene blue product can promise that staining is impossible under every circumstance, but the leuco form removes the ordinary cause of it.

If you are weighing formats rather than brands, our ranked guide to the best methylene blue gummies puts the field side by side on purity, dose, published COAs and sugar content.

Interactions and Who Should Avoid Methylene Blue

This is the part of the decision that has nothing to do with which brand you pick. Methylene blue acts as a monoamine oxidase inhibitor, which is why the most important caution attached to it concerns serotonergic medication. Anyone taking an SSRI, SNRI, tricyclic antidepressant, MAOI, triptan or another serotonergic drug should treat combined use as off the table and speak to their doctor before considering methylene blue in any form or from any brand.

Two other groups have clear reasons for caution. People with G6PD deficiency should not use methylene blue at all, and neither should anyone who is pregnant or breastfeeding. Kidney or liver impairment, and any regular prescription at all, are reasons to have the conversation with a clinician first rather than working it out from a label. None of this is brand-specific and none of it is optional reading — it applies identically to Meraki Blu, to NooBlue, and to every other methylene blue product on the market.

Beyond interactions, the commonly reported effects are mild and mostly cosmetic: blue-green urine is expected and harmless, and some people notice mild nausea, particularly on an empty stomach. Our full write-up of methylene blue side effects goes through what is typical, what is dose-related, and what warrants stopping. This article is general information, not medical advice.

What Meraki Blu Reviews Actually Say

Star ratings for Meraki Blu are high across the brand’s own site, reseller pages and Trustpilot, and the praise is consistent: steadier daytime energy with no spike or jitters, clearer focus, and, for some, a noticeable difference within the first one to two weeks. Scan the lower-rated reviews and the same three complaints keep surfacing. Price per dose, which the 150 mg bottle drives up. Thin usage directions, which matter more for a dropper product than for a capsule. And billing or cancellation friction on subscriptions.

The one review that should carry the most weight is not a star rating at all: a third-party lab test posted on Reddit that flagged a high bacterial count and concluded the tested unit did not meet the pharmaceutical-grade checklist. Aggregate ratings measure how a product feels; a batch COA measures what is in it. Weight them accordingly.

Who Should Buy Meraki — and Who Shouldn’t

Meraki Blu is a reasonable consideration if you specifically want a liquid format, you’re comfortable verifying the batch COA yourself before you dose, and you’ve read the subscription terms. The brand’s testing program, taken at face value, is more thorough than most of the market.

It’s a weaker fit if you want a fixed, repeatable dose with zero measurement error, if you’d rather not manage a dropper to stay in the low-dose range the research supports, or if the conflicting independent purity assessments make you want a product where the dose and concentration are locked in by design. In those cases a pharmaceutical-grade capsule or a defined-concentration solution removes the variables that actually determine whether methylene blue does anything for you. You can compare the full US field on our shop page.

Frequently Asked Questions

Is Meraki methylene blue safe?

Meraki markets USP pharmaceutical grade with multi-test batch screening, which is the right standard for oral use. However, independent assessments of the brand have not been unanimous, with at least one flagging a high microbial count on a tested unit. The responsible answer is that safety with any methylene blue product depends on verifying the batch-specific Certificate of Analysis — assay, heavy metals, and microbial counts — rather than relying on marketing claims. Methylene blue also interacts with serotonergic medications, so anyone on SSRIs, SNRIs, or MAOIs should treat that as a hard contraindication regardless of brand.

How does Meraki methylene blue compare to NooBlue?

Both position as pharmaceutical/USP grade with published COAs. The practical differences are format and dose control: Meraki’s flagship is a 150 mg liquid, while NooBlue offers both a fixed-dose 5 mg capsule and a defined-concentration 1% solution, which make it easier to stay in the low, accurate dose range the research is built on. Verify the batch COA with either brand before buying.

What dose of methylene blue is supported by research?

The cognitive and mitochondrial research uses low doses of USP-grade methylene blue, typically in the single-digit-milligram to low-tens range, with a hormetic curve where low doses help and higher doses lose the benefit. Bottle size (e.g. 150 mg) is not a dose — the dose is the small amount you actually take, which is why concentration accuracy and a predictable format matter more than container volume.

Is the 99.9% purity claim meaningful?

Only if it’s backed by a batch-matched Certificate of Analysis showing the measured assay and contaminant values for the specific lot you received. A purity number on a homepage is a marketing claim; the same number on a lab-issued COA tied to your bottle’s batch number is verification. Always ask for the latter.

Where is Meraki methylene blue made?

Meraki Medicinal states its product is made in a US cGMP facility, with the company based in Las Vegas, Nevada. As with any brand, US manufacturing and a cGMP claim are positive signals but not substitutes for reviewing the actual third-party test results for your batch.

Is Meraki methylene blue any good?

On format and testing posture it is a credible product: USP-grade positioning, US cGMP manufacturing, and a marketed four-test-per-batch program with published Certificates of Analysis. The reservations are that independent assessments of the brand have not been unanimous, that the 30 ml dropper puts dose accuracy on the buyer, and that the small bottle makes it expensive per milligram. Whether that adds up to “good” depends on whether you want a liquid and will check the batch COA yourself.

What is Meraki methylene blue used for?

It is sold as a supplement positioned around mitochondrial energy support and cognitive performance, and that is also where the research interest sits — studies suggest low-dose methylene blue affects mitochondrial respiration, with a hormetic curve where low doses behave differently from high ones. It is not sold or intended to treat, diagnose or prevent any condition, and it should not be used as a substitute for care from a qualified clinician.

How many drops of Meraki methylene blue is a 5 mg dose?

Meraki Blu is 150 mg in 30 ml, or 5 mg per milliliter, so a 5 mg dose is one full 1 ml dropper — roughly 20 drops from a standard dropper, not ten. The ten-drop figure you will see quoted applies to 1% solutions (10 mg per milliliter), which are twice as concentrated. Treat that as arithmetic rather than instruction: droppers differ, and the serving size printed on your own bottle is the figure that governs. If drop-counting is the part you would rather not manage daily, a fixed-dose capsule or gummy removes it.

Does methylene blue stain your teeth?

Conventional oxidized methylene blue — liquids, powders and standard gummies — is a deep blue dye, and it can temporarily tint the mouth, tongue and dental work on contact. Diluting a liquid in plenty of water and using a straw reduces it, and the tinting normally fades. A gummy built on the reduced leucomethylene blue form is colorless at the point of contact, which removes the usual cause of blue mouth, though no oral methylene blue product can guarantee staining will never occur.

Does Meraki publish a Certificate of Analysis?

Meraki markets publicly available COAs as part of its four-test program. The step that matters is matching the certificate to the batch number printed on the bottle you actually received — a generic sample document tells you nothing about your lot. That is the same standard we would ask you to apply to NooBlue.

How much does Meraki methylene blue cost?

Meraki Blu’s flagship 30 ml bottle holds 150 mg of methylene blue and is priced around $35, which works out to roughly $1.17 per 5 mg serving — a premium cost per dose driven by the small bottle size rather than higher quality. A larger 50 ml 1% solution or a fixed-dose capsule generally costs less per accurate dose. As always, compare cost per verified dose, not the sticker price on the bottle.

How long does it take to see results from methylene blue?

Expect two timelines. Methylene blue reaches peak blood levels within an hour or two of an oral dose, and Meraki’s marketing leans on “within minutes” clarity claims; treat those as anecdotes rather than data. The research signal comes from low, precisely controlled doses, and most users who notice anything describe a subtle steadiness after one to two weeks of consistent morning dosing, not a stimulant kick. If you feel nothing after a month at a verified low dose, a bigger dose is not the fix: the curve is hormetic, and the benefit fades as the dose climbs.

Is Meraki Blu sold on Amazon, and is it the same product?

There is an Amazon listing for Meraki Blu, and it sells in volume. Two cautions before you use it. First, the listing describes the product as a 1% solution, while Meraki’s own site specifies 150 mg in a 30 ml bottle with a 1 ml dropper, which is 5 mg per ml, or 0.5%; if you dose by drop count, that gap is a two-fold error. Second, marketplace stock can come from third-party sellers, so the batch number on your bottle may not match a COA on Meraki’s site. Buy from the brand’s own storefront and match the batch before your first dose.